OraSure Technologies (OSUR) Current Ratio: History & Chart

OraSure Technologies, Inc.(OSUR)

Medical - Instruments & Supplies · Bethlehem, PA

$3.89-0.23 (-5.47%)

Delayed quote: Oct 6, 2026, 12:20 PM EDT

About OraSure Technologies, Inc.

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.

Bethlehem, PA

500 employees

www.orasure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Carrie Eglinton Manner

View full financials

OSUR Current Ratio Metrics

CURRENT RATIO

8.88

CURRENT RATIO AVG TTM

7.01

CURRENT RATIO AVG 3Y

9.23

CURRENT RATIO AVG 5Y

7.60

CURRENT RATIO AVG 10Y

7.80

CURRENT RATIO AVG 15Y

7.06

CURRENT RATIO AVG 20Y

7.21

CURRENT VS TTM AVG

+26.54%

CURRENT VS 3Y AVG

-3.81%

CURRENT VS 5Y AVG

+16.81%

CURRENT VS 10Y AVG

+13.77%

CURRENT VS 15Y AVG

+25.69%

CURRENT VS 20Y AVG

+23.18%

SECTOR MEDIAN · HEALTHCARE

3.58

median of 752 covered companies

CURRENT VS SECTOR MEDIAN

+147.91%

vs the sector median at left

NAME	MARKET CAP	CURRENT RATIO	TTM	3Y	5Y
OraSure Technologies, Inc. (OSUR)	$267.48M	8.88	7.01	9.23	7.60
EyePoint Pharmaceuticals, Inc. (EYPT)vs ›	$267.03M	4.50	8.35	6.79	6.91
Eupraxia Pharmaceuticals Inc. (EPRX)vs ›	$266.50M	16.00	13.11	8.33	7.81
Inhibikase Therapeutics, Inc. (IKT)vs ›	$266.05M	15.82	24.04	14.70	12.06
Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›	$263.05M	13.89	8.37	7.38	15.00
Palisade Bio, Inc. (PALI)vs ›	$261.24M	24.26	16.09	10.56	7.83
Scribe Therapeutics Inc. (SCTX)vs ›	$273.40M	N/A	N/A	N/A	N/A
Rocket Pharmaceuticals, Inc. (RCKT)vs ›	$274.62M	9.24	7.84	8.19	10.90
Anika Therapeutics, Inc. (ANIK)vs ›	$258.23M	4.48	4.80	5.23	5.23
Fate Therapeutics, Inc. (FATE)vs ›	$275.66M	4.85	6.69	6.56	6.64

NAME

MARKET CAP

CURRENT RATIO

TTM

OraSure Technologies, Inc. (OSUR)

$267.48M

8.88

7.01

9.23

7.60

EyePoint Pharmaceuticals, Inc. (EYPT)vs ›

$267.03M

4.50

8.35

6.79

6.91

Eupraxia Pharmaceuticals Inc. (EPRX)vs ›

$266.50M

16.00

13.11

8.33

7.81

Inhibikase Therapeutics, Inc. (IKT)vs ›

$266.05M

15.82

24.04

14.70

12.06

Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›

$263.05M

13.89

8.37

7.38

15.00

Palisade Bio, Inc. (PALI)vs ›

$261.24M

24.26

16.09

10.56

7.83

Scribe Therapeutics Inc. (SCTX)vs ›

$273.40M

N/A

Rocket Pharmaceuticals, Inc. (RCKT)vs ›

$274.62M

9.24

7.84

8.19

10.90

Anika Therapeutics, Inc. (ANIK)vs ›

$258.23M

4.48

4.80

5.23

Fate Therapeutics, Inc. (FATE)vs ›

$275.66M

4.85

6.69

6.56

6.64

Current Ratio FAQ

What is the current ratio for OraSure Technologies, Inc. (OSUR)?

The current ratio for OSUR stock is 8.88.

Is OraSure Technologies, Inc.'s current ratio high or low?

The current ratio of 8.88 is 17% above its 5-year average of 7.60, around the middle of its 5-year range (3.90–12.60).

What is the TTM average current ratio for OraSure Technologies, Inc. (OSUR)?

The TTM average current ratio for OSUR stock is 7.01.

What is the 3Y average current ratio for OraSure Technologies, Inc. (OSUR)?

The 3Y average current ratio for OSUR stock is 9.23.

What is the 5Y average current ratio for OraSure Technologies, Inc. (OSUR)?

The 5Y average current ratio for OSUR stock is 7.60.

What is the 10Y average current ratio for OraSure Technologies, Inc. (OSUR)?

The 10Y average current ratio for OSUR stock is 7.80.

What is the 15Y average current ratio for OraSure Technologies, Inc. (OSUR)?

The 15Y average current ratio for OSUR stock is 7.06.

What is the 20Y average current ratio for OraSure Technologies, Inc. (OSUR)?

The 20Y average current ratio for OSUR stock is 7.21.

DATE	CURRENT RATIO
2026-06-30	8.88
2026-03-31	5.46
2025-12-31	6.58
2025-09-30	7.03
2025-06-30	7.12
2025-03-31	12.34
2024-12-31	9.95
2024-09-30	12.60
2024-06-30	12.17
2024-03-31	11.97
2023-12-31	9.77
2023-09-30	8.71
2023-06-30	7.36
2023-03-31	6.23
2022-12-31	4.71
2022-09-30	3.90
2022-06-30	4.08
2022-03-31	4.83
2021-12-31	4.40
2021-09-30	5.34
2021-06-30	6.12
2021-03-31	6.55
2020-12-31	6.21
2020-09-30	8.14
2020-06-30	10.40
2020-03-31	8.48
2019-12-31	6.86
2019-09-30	7.72
2019-06-30	6.99
2019-03-31	7.52
2018-12-31	7.84
2018-09-30	9.71
2018-06-30	9.58
2018-03-31	9.29
2017-12-31	6.88
2017-09-30	7.86
2017-06-30	8.87
2017-03-31	9.88
2016-12-31	9.02
2016-09-30	6.87
2016-06-30	5.61
2016-03-31	6.60
2015-12-31	5.42
2015-09-30	4.78
2015-06-30	8.03
2015-03-31	7.03
2014-12-31	4.96
2014-09-30	5.15
2014-06-30	7.87
2014-03-31	7.47
2013-12-31	6.30
2013-09-30	5.76
2013-06-30	6.74
2013-03-31	6.28
2012-12-31	7.12
2012-09-30	7.27
2012-06-30	2.52
2012-03-31	2.61
2011-12-31	2.40
2011-09-30	1.77
2011-06-30	4.84
2011-03-31	5.17
2010-12-31	4.95
2010-09-30	5.26
2010-06-30	4.53
2010-03-31	8.48
2009-12-31	6.81
2009-09-30	7.60
2009-06-30	9.23
2009-03-31	8.97
2008-12-31	6.95
2008-09-30	9.08
2008-06-30	8.53
2008-03-31	9.38
2007-12-31	6.81
2007-09-30	8.27
2007-06-30	8.33
2007-03-31	8.42
2006-12-31	6.79
2006-09-30	9.39
2006-06-30	9.91
2006-03-31	11.67
2005-12-31	9.44
2005-09-30	8.03
2005-06-30	7.98
2005-03-31	7.92
2004-12-31	7.24
2004-09-30	8.01
2004-06-30	7.37
2004-03-31	8.28
2003-12-31	7.71
2003-09-30	3.68
2003-06-30	3.60
2003-03-31	3.84
2002-12-31	4.06
2002-09-30	3.81

DATE

CURRENT RATIO

2026-06-30

8.88

2026-03-31

5.46

2025-12-31

6.58

2025-09-30

7.03

2025-06-30

7.12

2025-03-31

12.34

2024-12-31

9.95

2024-09-30

12.60

2024-06-30

12.17

2024-03-31

11.97

2023-12-31

9.77

2023-09-30

8.71

2023-06-30

7.36

2023-03-31

6.23

2022-12-31

4.71

2022-09-30

3.90

2022-06-30

4.08

2022-03-31

4.83

2021-12-31

4.40

2021-09-30

5.34

2021-06-30

6.12

2021-03-31

6.55

2020-12-31

6.21

2020-09-30

8.14

2020-06-30

10.40

2020-03-31

8.48

2019-12-31

6.86

2019-09-30

7.72

2019-06-30

6.99

2019-03-31

7.52

2018-12-31

7.84

2018-09-30

9.71

2018-06-30

9.58

2018-03-31

9.29

2017-12-31

6.88

2017-09-30

7.86

2017-06-30

8.87

2017-03-31

9.88

2016-12-31

9.02

2016-09-30

6.87

2016-06-30

5.61

2016-03-31

6.60

2015-12-31

5.42

2015-09-30

4.78

2015-06-30

8.03

2015-03-31

7.03

2014-12-31

4.96

2014-09-30

5.15

2014-06-30

7.87

2014-03-31

7.47

2013-12-31

6.30

2013-09-30

5.76

2013-06-30

6.74

2013-03-31

6.28

2012-12-31

7.12

2012-09-30

7.27

2012-06-30

2.52

2012-03-31

2.61

2011-12-31

2.40

2011-09-30

1.77

2011-06-30

4.84

2011-03-31

5.17

2010-12-31

4.95

2010-09-30

5.26

2010-06-30

4.53

2010-03-31

8.48

2009-12-31

6.81

2009-09-30

7.60

2009-06-30

9.23

2009-03-31

8.97

2008-12-31

6.95

2008-09-30

9.08

2008-06-30

8.53

2008-03-31

9.38

2007-12-31

6.81

2007-09-30

8.27

2007-06-30

8.33

2007-03-31

8.42

2006-12-31

6.79

2006-09-30

9.39

2006-06-30

9.91

2006-03-31

11.67

2005-12-31

9.44

2005-09-30

8.03

2005-06-30

7.98

2005-03-31

7.92

2004-12-31

7.24

2004-09-30

8.01

2004-06-30

7.37

2004-03-31

8.28

2003-12-31

7.71

2003-09-30

3.68

2003-06-30

3.60

2003-03-31

3.84

2002-12-31

4.06

2002-09-30

3.81

Current Ratio: 8.88

OSUR Current Ratio

OSUR Average Current Ratio Chart

OSUR Current vs Average Current Ratio Chart

OSUR Current Ratio Metrics

OSUR Competitors' Current Ratio

Liquidity Analysis

Current Ratio Formula & Definition

Current Ratio FAQ

OSUR Current Ratio History

Related Metrics